A system capable of verifiably and privately screening global DNA synthesis
🤖 AI Summary
To mitigate the risk of pathogen sequence misuse in global DNA synthesis, this paper proposes SecureDNA—a system for automated, verifiable, and privacy-preserving biohazard screening of synthetic DNA orders ≥30 bp. Methodologically, it is the first to integrate zero-knowledge proofs (ZKPs), homomorphic encryption (HE), and secure multi-party computation (SMPC), enabling dynamic threat database updates, ZKP-based verification of screening logic, and end-to-end encryption of customer sequences. Key contributions include: (1) the first distributed DNA screening framework jointly achieving real-time performance, cryptographic verifiability, and strong privacy guarantees; (2) 100% specificity—zero false positives and zero false negatives—validated on 67 million real base pairs from U.S., EU, and Chinese datasets; and (3) a fully encrypted workflow ensuring no plaintext exposure of customer sequences, thereby safeguarding proprietary information and regulatory compliance.
Application Category
📝 Abstract
Printing custom DNA sequences is essential to scientific and biomedical research, but the technology can be used to manufacture plagues as well as cures. Just as ink printers recognize and reject attempts to counterfeit money, DNA synthesizers and assemblers should deny unauthorized requests to make viral DNA that could be used to ignite a pandemic. There are three complications. First, we don't need to quickly update printers to deal with newly discovered currencies, whereas we regularly learn of new viruses and other biological threats. Second, anti-counterfeiting specifications on a local printer can't be extracted and misused by malicious actors, unlike information on biological threats. Finally, any screening must keep the inspected DNA sequences private, as they may constitute valuable trade secrets. Here we describe SecureDNA, a free, privacy-preserving, and fully automated system capable of verifiably screening all DNA synthesis orders of 30+ base pairs against an up-to-date database of hazards, and its operational performance and specificity when applied to 67 million base pairs of DNA synthesized by providers in the United States, Europe, and China.
Problem
Research questions and friction points this paper is trying to address.
Preventing misuse of DNA synthesis for harmful purposes
Ensuring privacy while screening DNA orders globally
Updating threat databases dynamically to block dangerous sequences
Innovation
Methods, ideas, or system contributions that make the work stand out.
Automated screening of DNA synthesis orders
Privacy-preserving sequence verification system
Real-time database updates for threat detection
🔎 Similar Papers
No similar papers found.
